Ambulatory blood pressure control and home blood pressure (morning and evening) lowering by N-channel blocker cilnidipine study
Not Applicable
- Conditions
- Essential Hypertension
- Registration Number
- JPRN-UMIN000003695
- Lead Sponsor
- Ajinomoto Pharmaceuticals Co., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant or possibly pregnant patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in blood pressure levels at home (early morning and before bedtime) or in physician's office
- Secondary Outcome Measures
Name Time Method Adverse events